CARDIOVASCULAR101 

Cardiovascular News, Help, Drugs

Cardiologist, Current Research

Heart Attacks, Stents

Heart Bypass, Transplant

Filter= SouthCarolina

 

  Exact Time

 

 * Search on anything here:         Like us:      Follow us:   

 

 * Featured New Sites! =>

 

    

 

    

   

 

* Z101.COM *

 

** Useful Links **
  • Obituaries101
  • Accident Lawyers101
  • FIRE101
  •  FIRE101 MOBILE
  • POLICE101
  • Protect101
  • School Directions
  •  

  • ** Car Websites **
  •   Corvettes 101
  •   Mustangs 101
  • New Cars 101
  • Luxury Cars 101
  • Exotic Cars 101
  •  

  • ** Sports Websites **
  • Lacrosse 101
  • Volleyball 101
  • Cross Country 101
  • Rowing 101
  • Rugby 101
  • Softball 101
  • Water Polo 101
  • Karate 101
  • TKD 101
  •  

  • ** Medical Websites **
  • Internal Medicine 101
  • Sports Medicine 101
  • Nursing 101
  • OccupationalTherapy101
  • Orthopedics 101
  • Podiatry 101
  • Psychiatry 101
  •  

  • Diseases 101
  • Depression 101
  • Lyme Disease 101
  • OCD101
  •  

  • ** Lawyers Websites **
  • * Find Lawyers 101 *
  • Accident Lawyers 101
  • Defense Lawyers 101
  • Divorce Lawyers 101
  • DWI Lawyers 101
  • Malpractice Lawyers 101
  • Personal Injury Lawyers 101
  • Real Estate Lawyers 101
  • Tax Lawyers 101
  • ** Most Popular Pages **

  •  

     

     

        

    * Internet Search Results 

      *** Search Filter: "SouthCarolina"

      

    eCFR :: 21 CFR 165.110 -- Bottled water.
    Mineral water shall be distinguished from other types of water by its constant level and relative proportions of minerals and trace elements at the point of emergence from the source, due account being taken of the cycles of natural fluctuations.

    Codex Standard for Mineral Waters | PDF | Minerals | Hygiene
    CODEX STANDARD FOR NATURAL MINERAL WATERS CODEX STAN 108-1981 1. SCOPE This standard applies to all packaged natural mineral waters offered for sale as food. It does not apply to natural mineral waters sold or used for other purposes. 2. DESCRIPTION 2.1 Definition of natural mineral water Natural mineral water is a water clearly distinguishable from ordinary drinking water because: a) it is ...

    21 CFR § 165.110 - Bottled water. | Electronic Code of ...
    Mineral water shall be distinguished from other types of water by its constant level and relative proportions of minerals and trace elements at the point of emergence from the source, due account being taken of the cycles of natural fluctuations.

    Bottled Water [Food and Drug Administration (FDA)] | AIChE
    Mineral Water – Water containing not less than 250 parts per million (ppm) total dissolved solids (TDS), coming from a source tapped at one or more bore holes or springs, originating from a geologically and physically protected underground water source; mineral water shall be distinguished from other types of water by its constant level and ...

    Natural mineral waters and spring water - Food Safety
    Natural mineral waters and spring water Categories of water There are different categories of waters intended for human consumption such as natural mineral waters and spring waters. Natural mineral waters may be distinguished from ordinary drinking water by their purity at source and their constant level of minerals.

    Bottled Water Labeling Requirements [Legal Compliance Guide]
    Master FDA bottled water labeling requirements and legal definitions. Ensure 21 CFR 165.110 compliance for spring, purified, and mineral water. Read now.

    APPENDIX II: Draft Revised Standard for Natural Mineral Waters
    APPENDIX II: Draft Revised Standard for Natural Mineral Waters (Advanced to Step 8 of the Codex Procedure) 1. SCOPE This standard applies to all packaged natural mineral waters offered for sale as food. It does not apply to natural mineral waters sold or used for other purposes. 2. DESCRIPTION 2.1 Definition of Natural Mineral Water Natural mineral water is a water clearly distinguishable from ...

    Natural mineral waters - EUR-Lex
    In general, natural mineral waters must comply at source with the microbiological criteria for drinking water and give satisfactory evidence of the protection of the source against all contamination.

    Mineral Water - an overview | ScienceDirect Topics
    This legislation covers the definition of natural mineral water, spring water and “other water,” their exploitation, treatment, microbiological criteria, chemical contaminants, sales description, labeling, and packaging. Directive 2009/54/EC defines the provisions applicable to the marketing and exploitation of natural mineral waters.

    Bottled Water/Carbonated Soft Drinks Guidance Documents ...
    Links to Bottled Water and Carbonated Soft Drinks Guidance Documents & Regulatory Information.

     

     

     

    * Latest OCD 101 News

           *** News Filter: "SouthCarolina"

     

     

      

     

  • New Jobs!!!
  • Obituaries101
  • FIRE101
  • POLICE101
  • PROTECT101
  • School Directions
  • * POPULAR:  
  • Democrats101
  • Republicans101
  • NewCars101
  • LuxuryCars101
  • CarbonCapture101
  • *Sponsored: *Teleflora Flowers GREAT Deals!

     

    *Click a bouquet and send it today:
               

     

        ~~> 30% Off Discount Page - ALL FLOWERS! <~~

     

    *More Savings: 
    Get well: 20%    Sympathy & Funeral: 20%

     

             Birthday: $15    New Baby 15% off    Anniversary 15% off
    Common Cardiovascular Symptoms & Warning Signs
    • Chest Pain or Pressure (Angina) — Sensation of squeezing, fullness, or tightness in the center of the chest that may radiate to the jaw, neck, back, or arm.
    • Shortness of Breath (Dyspnea) — Difficulty breathing or feeling winded during routine activities, exertion, or while lying flat in bed.
    • Palpitations or Irregular Heartbeat — Sensations of a racing, fluttering, pounding, or skipping heart rate.
    • Unexplained Dizziness or Lightheadedness — Sudden feelings of faintness, loss of balance, or near-syncope linked to decreased blood flow to the brain.
    • Swelling in the Extremities (Edema) — Fluid retention causing notable swelling in the legs, ankles, feet, or abdomen.
    • Unusual Fatigue and Weakness — Persistent tiredness or exhaustion during simple daily tasks, often an early warning sign of heart failure.
    • Cold Sweats or Diaphoresis — Sudden onset of unexplained profuse sweating accompanied by chest discomfort or anxiety.
    • Cyanosis or Pale Skin Tone — A bluish or abnormally pale discoloration of the skin, lips, or nail beds due to poor oxygen circulation.
    • Persistent Coughing or Wheezing — Chronic cough producing white or pink blood-tinged mucus caused by fluid accumulation in the lungs.
    • Pain in the Extremities (Claudication) — Cramping or aching in the calves, thighs, or hips during walking, indicating peripheral artery disease.

      

    * Useful Government Health Sites:                               
    Current Cardiovascular Treatments
    • Dual GIP/GLP-1 Receptor Agonists — Advanced metabolic agents like tirzepatide cut major adverse cardiovascular events, reduce systemic vascular inflammation, and improve heart failure outcomes.
    • Pulsed-Field Ablation (PFA) — Non-thermal electroporation therapy replacing traditional radiofrequency ablation to treat atrial fibrillation with greater tissue selectivity and safety.
    • SGLT2 Inhibitor Therapy — Guideline-directed medical treatment (e.g., dapagliflozin, empagliflozin) initiated early to reduce hospitalizations and mortality across heart failure spectrums.
    • Targeted siRNA & Lipid Gene Therapy — Small interfering RNA injectables (like inclisiran) and gene-editing therapies (VERVE-102) providing long-term LDL-C reduction with single-dose schedules.
    • Transcatheter Valve Therapies (TAVR / TMVR) — Minimally invasive catheter interventions for replacing or repairing severe aortic, mitral, and tricuspid valve stenosis/regurgitation without open-heart surgery.
    • Aldosterone Synthase Inhibitors — Targeted hormonal pathway medications, such as baxdrostat, designed to treat treatment-resistant hypertension by lowering aldosterone production.
    • Left Bundle Branch Area Pacing (LBBAP) — Conduction system pacing delivering direct physiological resynchronization as a superior alternative to traditional cardiac resynchronization therapy.
    • Dual Endothelin Receptor Antagonists — Novel oral therapies like aprocitentan used in combination regimes to target resistant high blood pressure through specialized vascular pathways.
    • Targeted Anti-Inflammatory Agents — Low-dose colchicine and specialized anti-inflammatory protocols aimed directly at preventing plaque rupture and reducing residual cardiovascular risk.
    • Mechanical Decompression Systems — Endovascular venous balloon technology and advanced left ventricular assist devices designed to acutely unload intracardiac pressures during heart failure crises.
    Key Milestones in Cardiovascular History
    • Discovery of Blood Circulation (1628) — William Harvey published De Motu Cordis, demonstrating for the first time that blood circulates continuously through the body pumped by the heart.
    • Invention of the Stethoscope (1816) — René Laennec invented the wooden stethoscope, allowing physicians to auscultate and diagnose internal cardiac sounds non-invasively.
    • First Human Electrocardiogram (1902) — Willem Einthoven developed the string galvanometer to record the electrical activity of the heart, inventing the modern ECG.
    • First Human Cardiac Catheterization (1929) — Werner Forssmann performed the first successful cardiac catheterization on himself, opening the path for modern interventional cardiology.
    • Launch of the Framingham Heart Study (1948) — A landmark long-term epidemiological study began, establishing major risk factors like high blood pressure, cholesterol, and smoking.
    • Development of the Cardiopulmonary Bypass (1953) — John Gibbon successfully used a heart-lung machine on a human patient, enabling modern open-heart surgery.
    • First Successful Human Heart Transplant (1967) — Dr. Christiaan Barnard performed the world's first human-to-human heart transplant in Cape Town, South Africa.
    • First Coronary Angioplasty (1977) — Andreas Grüntzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) to open blocked arteries.
    • Introduction of Coronary Stents (1986) — Ulrich Sigwart and Jacques Puel implanted the first coronary stent in a human heart to prevent artery restenosis.
    • First TAVR Procedure (2002) — Alain Cribier performed the first Transcatheter Aortic Valve Replacement, revolutionizing treatment for aortic stenosis without open-heart surgery.
    Current Cardiovascular Research & Breakthroughs
    • Gene-Editing for Lipid Lowering — Advanced base-editing and RNA therapies (such as VERVE-102) show potential for permanently reducing LDL cholesterol with single-dose targeted gene inactivation.
    • AI-Driven Predictive Diagnostics — Deep learning algorithms now evaluate polygenic risk scores and real-time imaging data to predict cardiac events years before clinical symptoms appear.
    • Stem Cell Remuscularization — Regenerative cardiac cell therapies using stem-cell-derived cardiomyocytes aim to repair post-infarct scar tissue and restore contractile function.
    • Pulsed-Field Ablation (PFA) — Non-thermal electroporation technology is transforming arrhythmia management by selectively isolating cardiac tissue with lower procedural risk.
    • Anti-Inflammatory Therapies — Target-specific anti-inflammatory drugs are being validated to reduce residual vascular risk and suppress ongoing atheroma plaque progression.
    • Transcatheter Valve Evolution (TMVR/TAVR) — Next-generation transcatheter systems are expanding treatment options for complex structural valve conditions without traditional open surgery.
    • Digital Twin Hemodynamic Modeling — Virtual patient-specific cardiac models integrate imaging and biomarkers to simulate interventional outcomes before execution.
    • Conduction System Pacing (LBBAP) — Left bundle branch area pacing is replacing traditional biventricular pacing to provide more natural physiological resynchronization.
    • Cardioprotective Metabolic Drugs — Broadening applications of SGLT2 inhibitors and GLP-1 receptor agonists demonstrate significant reductions in heart failure admissions and vascular events.
    • Novel Aldosterone Synthase Inhibitors — New drug classes like Baxdrostat provide target-specific control for resistant hypertension by directly modulating hormone pathways.

    CARDIOVASCULAR101.COM --- Cardiovascular Information, News, and Resources, Lots More
    Need to Find information on any subject? ASK THE CARDIOVASCULAR101 GURU!

     * Contact us:  support@z101.com
     
                                      

    Copyright � 2007---2026 CARDIOVASCULAR101.COM